Oruka Therapeutics, Inc. (ORKA) Insider Trading
Over the last 3 months, ORKA insiders made 0 open-market buys and 41 sales, a net sale of -$313.4M (SEC Form 4). Over the last 6 months, 159 institutions increased and 80 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
41
Net (3m)
-$313.4M
Insider trades by month Buys Sells
Mar
Apr
May
Jun
Jul
Aug
Context3-month price +65.7%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 25, 2026 | Edwards Larry Toddofficer: Chief Commercial Officer | Grant | 20,000 | $102.42 |
| Aug 25, 2026 | Edwards Larry Toddofficer: Chief Commercial Officer | Grant | 100,000 | — |
| Aug 17, 2026 | Goncalves Joanaofficer: Chief Medical Officer | Sell | 2,480 | $112.56 |
| Aug 17, 2026 | Goncalves Joanaofficer: Chief Medical Officer | Sell | 3,320 | $112.01 |
| Aug 17, 2026 | Goncalves Joanaofficer: Chief Medical Officer | Sell | 300 | $110.52 |
| Aug 17, 2026 | Goncalves Joanaofficer: Chief Medical Officer | Sell | 900 | $109.65 |
| Aug 17, 2026 | Goncalves Joanaofficer: Chief Medical Officer | Option | 3,500 | $6.84 |
| Aug 14, 2026 | Agarwal Arjunofficer: Senior Vice President, Finance | Option | 8,542 | $12.50 |
| Aug 14, 2026 | Quinlan Paul Tofficer: General Counsel | Sell | 3,847 | $111.14 |
| Aug 14, 2026 | Quinlan Paul Tofficer: General Counsel | Sell | 9,193 | $110.00 |
| Aug 14, 2026 | Quinlan Paul Tofficer: General Counsel | Sell | 10,200 | $109.11 |
| Aug 14, 2026 | Quinlan Paul Tofficer: General Counsel | Sell | 14,696 | $107.97 |
| Aug 14, 2026 | Quinlan Paul Tofficer: General Counsel | Sell | 10,434 | $107.14 |
| Aug 14, 2026 | Quinlan Paul Tofficer: General Counsel | Sell | 3,630 | $106.05 |
| Aug 14, 2026 | Quinlan Paul Tofficer: General Counsel | Option | 10,000 | $7.80 |
| Aug 14, 2026 | Quinlan Paul Tofficer: General Counsel | Option | 42,000 | $12.50 |
| Aug 14, 2026 | Agarwal Arjunofficer: Senior Vice President, Finance | Sell | 2,358 | $108.46 |
| Aug 14, 2026 | Agarwal Arjunofficer: Senior Vice President, Finance | Sell | 2,142 | $107.71 |
| Aug 14, 2026 | Agarwal Arjunofficer: Senior Vice President, Finance | Sell | 1,268 | $106.63 |
| Aug 14, 2026 | Agarwal Arjunofficer: Senior Vice President, Finance | Sell | 2,132 | $105.57 |
| Aug 14, 2026 | Agarwal Arjunofficer: Senior Vice President, Finance | Sell | 2,100 | $104.67 |
| Aug 14, 2026 | Agarwal Arjunofficer: Senior Vice President, Finance | Option | 1,458 | $34.39 |
| Jul 15, 2026 | Goncalves Joanaofficer: Chief Medical Officer | Sell | 400 | $84.36 |
| Jul 15, 2026 | Goncalves Joanaofficer: Chief Medical Officer | Sell | 300 | $87.25 |
| Jul 15, 2026 | Goncalves Joanaofficer: Chief Medical Officer | Sell | 3,803 | $86.68 |
| Jul 15, 2026 | Goncalves Joanaofficer: Chief Medical Officer | Sell | 2,497 | $85.86 |
| Jul 15, 2026 | Goncalves Joanaofficer: Chief Medical Officer | Option | 3,500 | $6.84 |
| Jul 13, 2026 | Agarwal Arjunofficer: Senior Vice President, Finance | Option | 1,458 | $34.39 |
| Jul 13, 2026 | Agarwal Arjunofficer: Senior Vice President, Finance | Sell | 5,656 | $84.90 |
| Jul 13, 2026 | Agarwal Arjunofficer: Senior Vice President, Finance | Sell | 3,743 | $84.26 |
Source: ORKA SEC Form 4 filings, latest Aug 25, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their ORKA positions over the last 6 months (SEC Form 13F).
Increased
159
New positions
165
Reduced
80
Sold out
29
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 9.1M | Aug 13, 2026 |
| FMR LLC | Increased | 7.4M | May 15, 2026 |
| BlackRock, Inc. | Increased | 5.0M | Aug 7, 2026 |
| VR Adviser, LLC | Unchanged | 4.1M | Aug 14, 2026 |
| VR ADVISER, LLC | Unchanged | 4.1M | May 15, 2026 |
| Fairmount Funds Management LLC | Unchanged | 3.7M | Aug 14, 2026 |
| FAIRMOUNT FUNDS MANAGEMENT LLC | Unchanged | 3.7M | May 15, 2026 |
| BLACKROCK, INC. | Reduced | 3.5M | May 13, 2026 |
| Capital World Investors | New Position | 3.4M | Aug 12, 2026 |
| RTW INVESTMENTS, LP | Increased | 3.1M | Aug 14, 2026 |
| STATE STREET CORP | Increased | 2.7M | Aug 7, 2026 |
| VIKING GLOBAL INVESTORS LP | Unchanged | 2.7M | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 2.4M | Aug 13, 2026 |
| PARADIGM BIOCAPITAL ADVISORS LP | Increased | 2.3M | May 15, 2026 |
| Paradigm Biocapital Advisors LP | Reduced | 2.1M | Aug 14, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.